Financial Statement

Ebix, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(In thousands, except share amounts)
  September 30,
2023		 December 31,
2022
ASSETS (Unaudited)  
Current assets:    
Cash and cash equivalents $71,162 $110,637
Receivables from service providers 8,523 4,223
Short-term investments 17,526 17,438
Restricted cash 10,465 8,210
Fiduciary funds - restricted 1,835 2,092
Trade accounts receivable, less allowances of $13,971 and $18,167, respectively 156,302 154,533
Other current assets 93,068 87,387
Total current assets 358,881 384,520
     
Property and equipment, net 53,154 52,448
Right-of-use assets 7,720 9,636
Goodwill 879,254 881,676
Intangibles, net 45,085 50,900
Indefinite-lived intangibles 16,647 16,647
Capitalized software development costs, net 16,184 15,342
Non Current Accounts receivable, less allowance 10,512 —
Deferred tax asset, net 123,887 96,290
Other assets 50,667 30,096
Total assets $1,561,991 $1,537,555
     
LIABILITIES AND STOCKHOLDERS’ EQUITY    
Current liabilities:    
Accounts payable and accrued liabilities $116,080 $99,194
Payables to service agents 31,479 11,299
Accrued payroll and related benefits 16,537 10,651
Working capital facility 15,341 3,367
Fiduciary funds - restricted 1,835 2,092
Revolving line of credit 444,902 449,902
Short-term debt 991 3,000
Current portion of long term debt and financing lease obligations, net of deferred financing costs of $3,287 and $469, respectively 170,502 190,866
Contract liabilities 40,832 32,028
Lease liability 2,739 3,354
Other current liabilities 24,113 25,784
Total current liabilities 865,351 831,537
     
Revolving line of credit — —
Long term debt and financing lease obligations, less current portion, net of deferred financing costs of $0 and $0, respectively 47 160
Contingent liability for accrued earn-out acquisition consideration 2,285 2,299
Contract liabilities 7,261 14,098
Lease liability 5,287 6,612
Deferred tax liability, net 1,150 1,150
Other liabilities 29,066 22,259
Total liabilities 910,447 878,115
     
     
Stockholders’ equity:    
Preferred stock, $0.10 par value, 500,000 shares authorized, no shares issued and outstanding at September 30, 2023 and December 31, 2022 — —
Series Y Convertible preferred stock, $0.10 par value, 350,000 shares authorized, no shares issued and outstanding at September 30, 2023 and December 31, 2022 — —
Common stock, $0.10 par value, 220,000,000 shares authorized, 30,899,335 issued and outstanding, at September 30, 2023, and 30,819,533 issued and outstanding at December 31, 2022 3,090 3,082
Additional paid-in capital 20,355 18,800
Retained earnings 811,866 814,780
Accumulated other comprehensive loss (224,226) (219,437)
Total Ebix, Inc. stockholders’ equity 611,085 617,225
Noncontrolling interest 40,459 42,215
Total stockholders’ equity 651,544 659,440
Total liabilities and stockholders’ equity $1,561,991 $1,537,555
Investor Home

Investor Contacts

EBIX Inc
1 Ebix Way, Johns Creek, Georgia 30097
Ph: 678-281-2027 Fax: 678-281-2019

IR@ebix.com

David Collins, Tanya Kamatu, Chris Eddy
Catalyst Global - 212-924-9800 or ebix@catalyst-ir.com

Ebix Named in Fortune’s 2017 100 Fastest-Growing Companies

Follow us

   

Ebix Inc.
1 Ebix Way, Johns Creek,
GA 30097

Tel: +1 (678) 281-2020
Fax: +1 (678) 281-2019

  • Join Us

Copyright © 2022 Ebix Inc. Terms Of Use | Privacy Statement